DFCI Pediatric Heme-Onc ex-pat reunion! #ASCO13 (@ City Tavern w/ 2 others) http://4sq.com/119TLGS
Cluster of financial analysts around the nivolumab/platinum for NSCLC poster (number 8072). Fascinating! #asco13
Good thing oncologists have access to potent anti-emetics! #ASCO13
Great chemical biology talk by Jay Bradner in the DLBCL session at #asco13 including name dropping Keyser Söze!
Also ... Do you need daily dosing of ibrutinib or cal-101 or can we get away with less (and how will we ever know)? #asco13
Impressive review of ibrutinib and CAL-101 data in DLBCL. No mention of resistance a la BRAF or imatinib. Is this coming? #ASCO13
Is it me or are there "session police" giving people (well-deserved) warnings for taking flash photos of slides during #asco13 sessions?
"Hot Pathways" for DLBCL. Would be more fun to have an interactive "Hot or Not" type session. #ASCO13
Good god. What an ordeal! #ASCO13 (@ Chicago O'Hare International Airport (ORD) - @fly2ohare w/ 129 others) http://4sq.com/18AU0n5
Total ground hold at ORD. Crap. #ASCO13
Oh Chicago ... You and your "Midwest thunderstorm days." You are going to make me miss my dinner tonight! #ASCO13
Off to Chicago for #ASCO13 (@ Seattle-Tacoma International Airport (SEA) - @portofseattle w/ 80 others) http://4sq.com/18BBYPa
Looking forward to #ASCO13. Is it me or is onc drug dev breaking into tribes: the Immunomodulators, the Sequencers/Inhibitors, and the Chemo
Hooray! #ASCO13 abstract day!
Looks like #ASCO13 will be the year of PD-1 and its cousins. Agree?